Despite the relatively high incidence, there is no FDA approved medical therapy for ASD at this time to address the core symptoms or the pathophysiological processes of this condition
Understanding Mounjaro: A Dual-Action Breakthrough Mounjaro is a unique medication because its the first and only FDA-approved treatment that activates two important gut hormone receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Recent genome-wide association studies have also identified LINC00944 as a novel locus associated with blood pressure regulation
Because MERCS are kinetic assemblies, pharmacological interventions must avoid hyper-stabilization that could precipitate mitochondrial Ca 2+ overload or misroute vital second messengers (Thoudam et al., 2023)
Herman G., Stevens C., Vandyck K., et al., Pharmacokinetics and Pharmacodynamics of Sitagliptin, an Inhibitor of Dipeptidyl Peptidase IV, in Healthy Subjects: Results From Two Randomized, DoubleBlind, PlaceboControlled Studies With Single Oral Doses, Clinical Pharmacology and Therapeutics 78, no
Role of cytokines in intervertebral disc degeneration: Pain and disc content
